Why U.S. generic drug manufacturing is shutting down
“We are systematically shutting down all of our U.S. manufacturing because we do not pay enough money for the drugs to the manufacturers, and not enough money is paid because of the middlemen,” says former generic drug executive Bill Simmons. https://cbsn.ws/3NtEDDj